Showing results (531-540 of 543) with videos related to

Sort By:
Pageof 55
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2016
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3Howard I Scher, Michael J Morris, Walter M Stadler, et al.
The Lancet. Oncology|November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
Clinical Trials (London, England)|August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
JAMA Oncology|August 8, 2024
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical TrialJulia S Wong, Hajime Uno, Angela C Tramontano, et al.
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Nature Medicine|December 16, 2022
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Sarah Abou Alaiwi, Wenxin Xu, et al.
Cancer Discovery|April 30, 2021
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in CholangiocarcinomaJames M Cleary, Srivatsan Raghavan, Qibiao Wu, et al.
Nature Reviews. Clinical Oncology|July 8, 2020
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaperArvind Dasari, Van K Morris, Carmen J Allegra, et al.
JCO Precision Oncology|January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal CancerRachel B Keller, Tali Mazor, Lynette Sholl, et al.
The Lancet. Oncology|November 27, 2025
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trialsCecilie D Amdal, Ragnhild S Falk, Ahu Alanya, et al.
Pageof 55